1.Progress in immunology diagnosis of food-born trematodes
Mali WU ; Anmei LI ; Wei LUO ; Zhilai GUO
Chinese Journal of Endemiology 2017;36(8):617-620
Food-born trematodes which parasitize liver, lung and intestine cause various trematodes diseases. There are a few common trematodes such as Clonorchis sinensis, Fasciola, Opisthorchis, Paragonimus, and Echinostoma. This review provides recent progress in techniques and methods for their immunodiagnosis. These methods are mainly used to diagnose with excretory-secretary antigen, recombinant antigen and antibodies of hosts, by means of enzyme-linked immunosorbent assay, immunoblotting, immunefluorescence, immunehistochemistry, proteomics and a lateral flow detection system so on. It is beneficial to improve diagnostic and accuracy rates when all this methods are used synthetically.
2.Quality standard for Shuwei Capsules
Peiyi LI ; Mali FENG ; Yanyan NIU ; Lili JIA ; Yupeng WU ;
Chinese Traditional Patent Medicine 1992;0(12):-
AIM: To study the quality standard for Shuwei Capsule (Resina Ferulae, Rhizoma Corydalis, Radix Aucklandiae, etc.). METHODS: Radix Aucklandiae, Rhizoma Cyperi were identified by TLC, and ferulic acid was determined by HPLC. RESULTS: TLC spots developed were fairly clear, and the blank test showed no interference. Ferulic acid showed a good linear relationship in the concentration range of 0.007~0.056?g and the average recovery was up to 98.51%, RSD was 2.64%. CONCLUSION: The method is simple with strong specificity and good reproducibility, and can be used as the quality control of this preparation.
3.Effects of Huang-Lian-Jie-Du-Decotion containing serum on expressions of autophagy related gene in macrophages
Honghong YU ; Mali WU ; Zhiwei ZHANG ; Rui CHEN ; Yun WU ; Zhixuan DUAN ; Weiyi TIAN
Chinese Journal of Immunology 2016;32(8):1150-1152,1164
Objective:To investigate the effects of Huang-Lian-Jie-Du-Decotion containing serum for the autophagy of RAM264.7 macrophages ,and to explore its possible anti-atherosclerosis mechanism .Methods:The SD rats were intervened with large , middle and small dose Huang-Lian-Jie-Du-Decotion to prepare containing drug serum .Cell proliferation was tested by MTT assay .The gene and protein expressions of Beclin 1, mTOR was assessed by fluorescent quantitative PCR and Western blot method .Results:Compared with the normal serum group ,Huang-Lian-Jie-Du-Decotion containing serum enhanced expression of the mRNA and protein level of Beclin1,and decreased the expression of mTOR and p-mTOR(P<0.05 or P<0.01).Conclusion:Huang-Lian-Jie-Du-Decotion containing serum could regulate the expressions of Beclin 1 and mTOR.These might be one of the mechanisms for preventing atheroscle-rosis.
4.Effects of viola-containing serum on phagocytosis and TOLL-like receptor expression of macrophage
Zhiwei ZHANG ; Kun CAI ; Mali WU ; Honghong YU ; Ling LENG ; Wenpeng YUE ; Weiyi TIAN
Chinese Journal of Immunology 2014;(6):759-762
Objective:To investigate effects of viola on macrophage TOLL-like receptor expression ,and tentatively explore the partial mechanism of viola intervention on macrophage function.Methods: Using viola water decoction lavage intervention in clean grade SD rats of conventional preparation containing serum ,In a certain concentration coculture with mouse peritoneal macrophages in 96-well plates.After 24 hours,cell phagocytosis activity was determined by neutral red uptake assay ,changes in expression levels of TLR-1,TLR-2,TLR-3,TLR-4,TLR-5 mRNAs were determined by RT-PCR.Results:Compared with the same concentration of normal serum group :(1 ) viola-containing serum group macrophage activity was significantly increased ( P<0.01 );( 2 ) Within certain concentration,viola containing serum group with increased or decreased expression levels of TLR -1,TLR-2,TLR-3 mRNA(P<0.05 or P<0.01 ) ,the expression level of TLR-4 was not significantly altered in each group ( P>0.05 ) ,and the expression level of TLR-5 was significantly increased in each group ( P<0.01 ).Conclusion:Viola-containing serum has obvious promoting effect on macrophage phag-ocytosis,the mechanism of which may be related to that this drug regulates and controls part of macrophage TOLL -like receptor expres-sion.
5.Exploration on the Mechanism of Aidi Injection in the Treatment of Ovarian Cancer Based on Network Pharmacology and Cell Experiments
Zhimin DENG ; Mali WU ; Fangfang DAI
Journal of Medical Research 2024;53(2):40-46
Objective To explore the key molecular targets and possible mechanisms of Aidi injection in the treatment of ovarian cancer using network pharmacology and cell experiments.Methods TCMSP database was used to screen the active ingredients and tar-gets of Aidi injection,and the abnormal expressed genes of ovarian cancer were screened,and the possible targets of Aidi injection in o-varian cancer were obtained after intersection analysis.Then,protein-protein interaction analysis,drug-compact-target network con-struction and enrichment analysis of possible targets were performed.The target was further screened,and the key genes related to the prognosis of ovarian cancer were experimentally verified.After treated with 50mg/ml Aidi injection,the cell proliferation ability was ob-served by CCK-8 assay,and the expression of core target genes was detected by real-time quantitative polymerase chain reaction.Results A total of 13 possible targets of Aidi injection in ovarian cancer were screened.These targets were mainly enriched in signaling pathways closely related to the occurrence and development of tumors,such as apoptosis,platinum resistance and interleukin-17.Among the 13 genes,claudin 4(CLDN4),secretory leukocyte peptidase inhibitor(SLPI)and baculoviral IAP repeat containing 5(BIRC5)were associated with the prognosis of ovarian cancer.Cell experiments showed that Aidi injection significantly inhibited the proliferation of ovari-an cancer cell,promoted the expression of BIRC5,a protective target of ovarian cancer,while significantly decreased the levels of ovarian cancer risk factors CLDN4 and SLPI.Conclusion Aidi injection may achieve multi-component,multi-target and multi-pathway anti-ovarian cancer and combination chemotherapy by affecting the expression of CLDN4,SLPI and BIRC5.